A Pragmatic Trial of a Low-dose Triple-Combination Blood Pressure Lowering Pill for Initial Treatment of Hypertension

Primary Results of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Comorbidities

Device Closure Versus Medical Therapy for Secondary Prevention in Cryptogenic Stroke Patients with High-Risk Patent Foramen Ovale

SMART-DATE: Safety of 6-Month Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes

Interim Report on the ANNEXA-4 Study: Andexanet For Reversal of Anticoagulation in Factor Xa – Associated Acute Major Bleeding

Blood Pressure Reduction in Black Barbershops

Anti-Inflammatory Therapy with Canakinumab and Incident Type 2 Diabetes: A Pre-Specified Key Secondary Endpoint of the CANTOS Trial

1-Year Outcomes of Perioperative Beta-blockade in Patients Undergoing Noncardiac Surgery

Lisinopril or Carvedilol for Prevention of Trastuzumab Induced Cardiotoxicity

Carvedilol for Prevention of Chemotherapy-Induced Cardiotoxicity – Results of the Prospective, Randomized, Double Blind, Placebo-Controlled Ceccy Trial

A Phase III, Randomized, International, Multicenter, Open label, with Blinded Adjudication of Outcomes, Non-Inferiority Clinical Trial to Explore the Safety and Efficacy of Ticagrelor Compared with Clopidogrel in Patients with Acute Coronary Syndrome with ST Elevation Treated with Thrombolysis. The TREAT Trial.

Loading Doses of Atorvastatin versus Placebo in Patients with Acute Coronary Syndromes and Planned Revascularization: The SECURE-PCI Trial

Efficacy of a Wearable Cardioverter-Defibrillator after Myocardial Infarction: Results of the Vest Prevention of Early Sudden Death Trial (VEST)

Cardiovascular Outcomes with Alirocumab After Acute Coronary Syndrome: Results of the ODYSSEY Outcomes Trial

Contemporary Use of Laser During Percutaneous Coronary Intervention: Long-Term Results From the Laser Veterans Affairs (LAVA) Multicenter Registry

Multicenter Study of MagLev Technology in Patients Undergoing Mechanical Circulatory Support Therapy with HeartMate 3 (MOMENTUM 3) - Long Term Outcomes

ACC expert

The FOURIER trial

The odyssey outcomes trial

Moving Targets, Thresholds, and Goals: Keeping the Clinician in the Know

Athletic Arteries in a Rat Model

The Effect of Dabigatran in Patients Suffering Myocardial Injury After Noncardiac Surgery

Renal Impairment Does Not Compromise Dabigatran Reversal by Idarucizumab

Exercise Test and Obesity Paradox

Getting to an improved Understanding of Low-Density Lipoprotein Cholesterol and Dyslipidemia Management (GOULD): A Registry of High Cardiovascular Risk Patients in the United States

The Effect of Ivabradine Administration on the Night Drop of Heart Rate in Patients With Inappropriate Sinus Tachycardia

Anti-Inflammatory Therapy with Canakinumab and Incident Type 2 Diabetes: A Pre-Specified Key Secondary Endpoint of the CANTOS Trial

AF Ablation as First Line Therapy - In Whom?